Viewing Study NCT03783403


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2025-12-28 @ 4:04 AM
Study NCT ID: NCT03783403
Status: TERMINATED
Last Update Posted: 2024-09-19
First Post: 2018-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module